Skip to content

Study · Animal study (in vivo) · mouse · 2026

13 results

Nicotinamide Mononucleotide Attenuates Inflammatory Activation, Choroidal Neovascularization, and Lesion-Associated Remodeling.

Wang J, Osada H, Chen S, Yamaguchi S, Hayashi K, Negishi K, Kurihara T, Ban N

Investigative ophthalmology & visual science1 Aug 2026

Summary

PurposeTo evaluate the therapeutic potential of nicotinamide mononucleotide (NMN) for modulating the neurovascular inflammatory microenvironment and blunting tissue remodeling in neovascular age-related macular degeneration (nAMD).MethodsA laser-induced choroidal neovascularization (CNV) model was established in C57BL/6J mice, and CNV lesion size was quantified on RPE/choroid flat mounts. Immunostaining evaluated myeloid cell accumulation and fibrosis-associated remodeling. Quantitative RT-PCR and Western blotting assessed inflammatory/angiogenic gene expression and signaling activation in the retina and RPE/choroid. In vitro, lipopolysaccharide (LPS)-stimulated bEnd.3 and primary mouse RPE cells and TGF-β-stimulated THP-1-derived macrophage cells were used to model inflammatory and profibrotic responses.ResultsNMN treatment significantly reduced CNV size in the laser-induced CNV model. This was accompanied by decreased myeloid cell accumulation within CNV lesions. NMN attenuated inflammatory and angiogenesis-related gene expression in the RPE/choroid and neural retina and reduced downstream signaling activation. In vitro, NMN suppressed LPS-induced inflammatory and proangiogenic responses in primary RPE cells and bEnd.3 endothelial cells and inhibited NF-κB activation. NMN further attenuated tissue remodeling, as shown by reduced collagen I-positive area under prolonged and delayed dosing regimens, together with decreased F4/80-positive area and α-smooth muscle actin-positive area within CNV lesions. In TGF-β-induced THP-1-derived macrophage cells, NMN suppressed profibrotic responses.ConclusionsOur findings indicate that NMN reduces inflammatory signaling and alleviates the inflammatory microenvironment in CNV, accompanied by decreased angiogenesis-related gene expression and fibrosis-related remodeling. By attenuating inflammatory activation and tissue remodeling processes, NMN warrants further evaluation as an adjunctive approach to limit CNV progression and late-stage tissue remodeling in nAMD.
CC BYText from Europe PMC. Highlighted sentences are the source of results.

Results from this study13

13 results from studies that gave the peptide. No result from this study comes from people.

  1. 01AnimalAnimal study (in vivo)Efficacy outcome

    In mice with laser-induced CNV, NMN significantly reduced CNV lesion size.

    In plain wordsIn mice, NMN reduced the size of laser-induced abnormal eye blood vessel lesions.

    Outcome
    DecreaseCNV lesion size
    Study

    mousen: not reported in source

    Laser-induced choroidal neovascularization in C57BL/6J mice
    Outcome group
    Angiogenesis · Eye
    Studied dose
    Dose not stated

    Source sentences

    Summary
    NMN treatment significantly reduced CNV size in the laser-induced CNV model.
    1 context sentence
    Summary · context
    A laser-induced choroidal neovascularization (CNV) model was established in C57BL/6J mice, and CNV lesion size was quantified on RPE/choroid flat mounts.
  2. 02AnimalAnimal study (in vivo)Efficacy outcome

    In mice with CNV, NMN decreased myeloid cell accumulation within lesions.

    In plain wordsIn mice, NMN reduced myeloid immune cell accumulation in eye lesions.

    Outcome
    DecreaseMyeloid cell accumulation
    Study

    mousen: not reported in source

    Laser-induced choroidal neovascularization in C57BL/6J mice
    Outcome group
    Immune response · Eye
    Studied dose
    Dose not stated

    Source sentences

    Summary
    This was accompanied by decreased myeloid cell accumulation within CNV lesions.
    2 context sentences
    Summary · context
    NMN treatment significantly reduced CNV size in the laser-induced CNV model.
    Summary · context
    A laser-induced choroidal neovascularization (CNV) model was established in C57BL/6J mice, and CNV lesion size was quantified on RPE/choroid flat mounts.
  3. 03AnimalAnimal study (in vivo)Efficacy outcome

    In mice with CNV, NMN attenuated inflammatory gene expression in the RPE/choroid and neural retina.

    In plain wordsIn mice, NMN reduced inflammatory gene expression in eye tissues.

    Outcome
    DecreaseInflammatory gene expression
    Study

    mousen: not reported in source

    Laser-induced choroidal neovascularization in C57BL/6J mice
    Outcome group
    Inflammation markers · Eye
    Studied dose
    Dose not stated

    Source sentences

    Summary
    NMN attenuated inflammatory and angiogenesis-related gene expression in the RPE/choroid and neural retina and reduced downstream signaling activation.
    1 context sentence
    Summary · context
    A laser-induced choroidal neovascularization (CNV) model was established in C57BL/6J mice, and CNV lesion size was quantified on RPE/choroid flat mounts.
  4. 04AnimalAnimal study (in vivo)Efficacy outcome

    In mice with CNV, NMN attenuated angiogenesis-related gene expression in the RPE/choroid and neural retina.

    In plain wordsIn mice, NMN reduced gene expression related to blood vessel growth in eye tissues.

    Outcome
    DecreaseAngiogenesis-related gene expression
    Study

    mousen: not reported in source

    Laser-induced choroidal neovascularization in C57BL/6J mice
    Outcome group
    Angiogenesis · Eye
    Studied dose
    Dose not stated

    Source sentences

    Summary
    NMN attenuated inflammatory and angiogenesis-related gene expression in the RPE/choroid and neural retina and reduced downstream signaling activation.
    1 context sentence
    Summary · context
    A laser-induced choroidal neovascularization (CNV) model was established in C57BL/6J mice, and CNV lesion size was quantified on RPE/choroid flat mounts.
  5. 05AnimalAnimal study (in vivo)Mechanism

    In mice with CNV, NMN reduced downstream signaling activation in eye tissues.

    In plain wordsIn mice, NMN reduced downstream signaling activation in eye tissues.

    Outcome
    DecreaseDownstream signaling activation
    Study

    mousen: not reported in source

    Laser-induced choroidal neovascularization in C57BL/6J mice
    Outcome group
    Receptor activity and mechanism · Eye
    Studied dose
    Dose not stated

    Source sentences

    Summary
    NMN attenuated inflammatory and angiogenesis-related gene expression in the RPE/choroid and neural retina and reduced downstream signaling activation.
    1 context sentence
    Summary · context
    A laser-induced choroidal neovascularization (CNV) model was established in C57BL/6J mice, and CNV lesion size was quantified on RPE/choroid flat mounts.
  6. 06AnimalAnimal study (in vivo)Efficacy outcome

    In mice with CNV, prolonged NMN dosing reduced collagen I-positive lesion area.

    In plain wordsIn mice, prolonged NMN treatment reduced collagen I-positive eye lesion area.

    Outcome
    DecreaseCollagen I-positive area with prolonged dosing
    Study

    mousen: not reported in source

    Laser-induced choroidal neovascularization in C57BL/6J mice
    Outcome group
    Organ injury · Eye
    Studied dose
    Dose not stated

    Source sentences

    Summary
    NMN further attenuated tissue remodeling, as shown by reduced collagen I-positive area under prolonged and delayed dosing regimens, together with decreased F4/80-positive area and α-smooth muscle actin-positive area within CNV lesions.
    1 context sentence
    Summary · context
    A laser-induced choroidal neovascularization (CNV) model was established in C57BL/6J mice, and CNV lesion size was quantified on RPE/choroid flat mounts.
  7. 07AnimalAnimal study (in vivo)Efficacy outcome

    In mice with CNV, delayed NMN dosing reduced collagen I-positive lesion area.

    In plain wordsIn mice, delayed NMN treatment reduced collagen I-positive eye lesion area.

    Outcome
    DecreaseCollagen I-positive area with delayed dosing
    Study

    mousen: not reported in source

    Laser-induced choroidal neovascularization in C57BL/6J mice
    Outcome group
    Organ injury · Eye
    Studied dose
    Dose not stated

    Source sentences

    Summary
    NMN further attenuated tissue remodeling, as shown by reduced collagen I-positive area under prolonged and delayed dosing regimens, together with decreased F4/80-positive area and α-smooth muscle actin-positive area within CNV lesions.
    1 context sentence
    Summary · context
    A laser-induced choroidal neovascularization (CNV) model was established in C57BL/6J mice, and CNV lesion size was quantified on RPE/choroid flat mounts.
  8. 08AnimalAnimal study (in vivo)Efficacy outcome

    In mice with CNV, NMN reduced F4/80-positive lesion area.

    In plain wordsIn mice, NMN reduced F4/80-positive immune cell area in eye lesions.

    Outcome
    DecreaseF4/80-positive area
    Study

    mousen: not reported in source

    Laser-induced choroidal neovascularization in C57BL/6J mice
    Outcome group
    Immune response · Eye
    Studied dose
    Dose not stated

    Source sentences

    Summary
    NMN further attenuated tissue remodeling, as shown by reduced collagen I-positive area under prolonged and delayed dosing regimens, together with decreased F4/80-positive area and α-smooth muscle actin-positive area within CNV lesions.
    1 context sentence
    Summary · context
    A laser-induced choroidal neovascularization (CNV) model was established in C57BL/6J mice, and CNV lesion size was quantified on RPE/choroid flat mounts.
  9. 09AnimalAnimal study (in vivo)Efficacy outcome

    In mice with CNV, NMN reduced α-smooth muscle actin-positive lesion area.

    In plain wordsIn mice, NMN reduced α-smooth muscle actin-positive area in eye lesions.

    Outcome
    Decreaseα-smooth muscle actin-positive area
    Study

    mousen: not reported in source

    Laser-induced choroidal neovascularization in C57BL/6J mice
    Outcome group
    Organ injury · Eye
    Studied dose
    Dose not stated

    Source sentences

    Summary
    NMN further attenuated tissue remodeling, as shown by reduced collagen I-positive area under prolonged and delayed dosing regimens, together with decreased F4/80-positive area and α-smooth muscle actin-positive area within CNV lesions.
    1 context sentence
    Summary · context
    A laser-induced choroidal neovascularization (CNV) model was established in C57BL/6J mice, and CNV lesion size was quantified on RPE/choroid flat mounts.
  10. 10LabIn vitro (cells)Efficacy outcome

    In LPS-stimulated primary RPE and bEnd.3 endothelial cells, NMN suppressed inflammatory responses.

    In plain wordsIn cells, NMN reduced inflammatory responses induced by LPS.

    Outcome
    DecreaseInflammatory responses
    Study

    mousen: not reported in source

    LPS-stimulated primary RPE and bEnd.3 endothelial cells
    Outcome group
    Inflammation markers · Eye
    Studied dose
    Dose not stated

    Source sentences

    Summary
    In vitro, NMN suppressed LPS-induced inflammatory and proangiogenic responses in primary RPE cells and bEnd.3 endothelial cells and inhibited NF-κB activation.
    1 context sentence
    Summary · context
    In vitro, lipopolysaccharide (LPS)-stimulated bEnd.3 and primary mouse RPE cells and TGF-β-stimulated THP-1-derived macrophage cells were used to model inflammatory and profibrotic responses.
  11. 11LabIn vitro (cells)Efficacy outcome

    In LPS-stimulated primary RPE and bEnd.3 endothelial cells, NMN suppressed proangiogenic responses.

    In plain wordsIn cells, NMN reduced responses that promote blood vessel growth after LPS stimulation.

    Outcome
    DecreaseProangiogenic responses
    Study

    mousen: not reported in source

    LPS-stimulated primary RPE and bEnd.3 endothelial cells
    Outcome group
    Angiogenesis · Eye
    Studied dose
    Dose not stated

    Source sentences

    Summary
    In vitro, NMN suppressed LPS-induced inflammatory and proangiogenic responses in primary RPE cells and bEnd.3 endothelial cells and inhibited NF-κB activation.
    1 context sentence
    Summary · context
    In vitro, lipopolysaccharide (LPS)-stimulated bEnd.3 and primary mouse RPE cells and TGF-β-stimulated THP-1-derived macrophage cells were used to model inflammatory and profibrotic responses.
  12. 12LabIn vitro (cells)Mechanism

    In LPS-stimulated primary RPE and bEnd.3 endothelial cells, NMN inhibited NF-κB activation.

    In plain wordsIn cells, NMN inhibited NF-κB activation after LPS stimulation.

    Outcome
    DecreaseNF-κB activation
    Study

    mousen: not reported in source

    LPS-stimulated primary RPE and bEnd.3 endothelial cells
    Outcome group
    Receptor activity and mechanism · Eye
    Studied dose
    Dose not stated

    Source sentences

    Summary
    In vitro, NMN suppressed LPS-induced inflammatory and proangiogenic responses in primary RPE cells and bEnd.3 endothelial cells and inhibited NF-κB activation.
    1 context sentence
    Summary · context
    In vitro, lipopolysaccharide (LPS)-stimulated bEnd.3 and primary mouse RPE cells and TGF-β-stimulated THP-1-derived macrophage cells were used to model inflammatory and profibrotic responses.
  13. 13LabIn vitro (cells)Efficacy outcome

    In TGF-β-stimulated THP-1-derived macrophages, NMN suppressed profibrotic responses.

    In plain wordsIn cells, NMN reduced fibrosis-promoting responses in TGF-β-stimulated macrophages.

    Outcome
    DecreaseProfibrotic responses
    Study

    humann: not reported in source

    TGF-β-stimulated THP-1-derived macrophages
    Outcome group
    Organ injury · Eye
    Studied dose
    Dose not stated

    Source sentences

    Summary
    In TGF-β-induced THP-1-derived macrophage cells, NMN suppressed profibrotic responses.
    1 context sentence
    Summary · context
    In vitro, lipopolysaccharide (LPS)-stimulated bEnd.3 and primary mouse RPE cells and TGF-β-stimulated THP-1-derived macrophage cells were used to model inflammatory and profibrotic responses.

AI wrote and checked these results. AI can make mistakes, so check important results against the source.

Version history

PepBank keeps every version of the data on this study. Status changes from Retraction Watch, Europe PMC and Crossref are listed with their source.

  1. Version 2Current

    21 Oct 2026, 15:58 UTC

    Study results updated

  2. Version 1

    21 Oct 2026, 12:50 UTC

    First added · source update from Europe PMC

Subjects

Terms as the source lists them.

PepBank is a research reference. Talk to a doctor before you use any peptide.